Korean J Radiol.
2023 Jun;24(6):482-497. 10.3348/kjr.2023.0324.
Diagnosing Hepatocellular Carcinoma Using Sonazoid Contrast-Enhanced Ultrasonography: 2023 Guidelines From the Korean Society of Radiology and the Korean Society of Abdominal Radiology
- Jeong WK
1 - Kang HJ2
- Choi SH3
- Park MS4
- Yu MH5
- Kim B6
- You MW7
- Lim S8
- Cho YS9
- Lee MW1
- Hwang JA1
- Lee JY2
- Kim JH2
- Joo I2
- Bae JS2
- Kim SY3
- Chung YE4
- Kim DH6
- Lee JM2
- Affiliations
-
- 1Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
- 2Department of Radiology and Research Institute of Radiological Science, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
- 3Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
- 4Department of Radiology and Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
- 5Department of Radiology, Konkuk University Hospital, Konkuk University College of Medicine, Seoul, Korea
- 6Department of Radiology, Seoul St. Mary Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
- 7Department of Radiology, Kyung Hee University Hospital, Kyung Hee University College of Medicine, Seoul, Korea
- 8Department of Radiology, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea
- 9Department of Radiology, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea
- KMID: 2542857
- DOI: http://doi.org/10.3348/kjr.2023.0324
Abstract
- Sonazoid, a second-generation ultrasound contrast agent, was introduced for the diagnosis of hepatic nodules. To clarify the issues with Sonazoid contrast-enhanced ultrasonography for the diagnosis of hepatocellular carcinoma (HCC), the Korean Society of Radiology and Korean Society of Abdominal Radiology collaborated on the guidelines. The guidelines are de novo, evidence-based, and selected using an electronic voting system for consensus. These include imaging protocols, diagnostic criteria for HCC, diagnostic value for lesions that are inconclusive on other imaging results, differentiation from non-HCC malignancies, surveillance of HCC, and treatment response after locoregional and systemic treatment for HCC.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Diagnosis of hepatocellular carcinoma using Sonazoid: a comprehensive review
- Modified CEUS LI-RADS using Sonazoid for the diagnosis of hepatocellular carcinoma
- Sonazoid-enhanced ultrasonography for noninvasive imaging diagnosis of hepatocellular carcinoma: special emphasis on the 2022 KLCA-NCC guideline
- Diagnosis of Hepatocellular Carcinoma with Gadoxetic Acid-Enhanced MRI: 2016 Consensus Recommendations of the Korean Society of Abdominal Radiology
- Focal Hepatic Eosinophilic Infiltration in Contrast-Enhanced Ultrasonography with Sonazoid: A Case Report
